Epidemiological overview on the effectiveness of mass screening for female cancer in Umbria, Italy

Using incidence, survival and mortality we tried to verify the effectiveness of mass-screening interventions for cervical uterine, breast, and colorectal cancer in females. Mortality data concern the period from 1978-2002. Incident cases derived from an ad hoc survey for 1978-1982 data and from the RTUP from 01/01/1994 to 31/12/2002. Relative survival rates were calculated for 1978-1982, 1994-1997 and 1998-2002 time intervals. All standardized mortality figures showed a steady trend. Incidence rates concerning cervical uterine cancer showed a decrease starting from the 1978-1982 period, whereas those for breast cancer had a constant increasing trend, and those for colorectal cancer increased up to 1997-1999 and later remained constant. For breast cancer the 5-year survival rate increased about 15% compared to the first period, for colon cancer there was less of an increase and the increase for cervical uterine cancer survival was only for the 1998-2002 period compared to the former ones. With constant incidence rates, improvement in survival from cervical uterine cancer may be due to a high number of cancer cases detected at an early stage. The effect of breast cancer screening on incidence is evident, though differences still did not influence mortality and survival. Colorectal cancer epidemiology can be considered as a prescreening pattern. Mortality, incidence and survival data allow a good overview for the effectiveness of screening procedures.

Female cancers; Screening; Incidence; Mortality; Survival

[1] Parkin D.M., Bray F., Ferlay J., Pisani P.: "Estimating the world cancer burden: Globocan 2000". Int. J. Cancer, 94, 153.

[2] Boyle P., Veronesi U., Tubiana M., Alexander F.E., Calais da Silva F., Denis L.J. et al.: "Special Paper. European School of Oncology Advisory Report to the European Commission for the'Europe Against Cancer Programme"'. Eur. J. Cancer, 1995, 9, 1395.

[3] AA.VY.: "ERA- Atlante 2006: Mortalita evitabile e contesto demografico" (www.e-r-a.it).

[4] Canosa A., Minelli L., Cassetti T., La Rosa F., Romagnoli C., Stracci F.: "La mortalita evitabile in Umbria, 1994-2004", Regione dell'Umbria, Perugia, 2006.

[5] Boyle P., Autier P., Bartelink H., Baselga J., Moffetta P., Burn J et al.: "European Code Against Cancer: Third Version (2003) and Scientific Justification". Annals. Oncol., 2003, 14, 973.

[6] Shapiro S.: "Evidence on screening for breast cancer from a randomized trial". Cancer, 1977, 39 (suppl.), 2772.

[7] Tabar L., Fagerberg G., Duffy S.W., Day N.E.: "The Swedish two county trial of mammographic screening for breast cancer: Recent result and calculation of benefit". J. Epidemiol. Community Health, 1989, 43, 107.

[8] F reedman D.A., Petitti D.B., Robins J.M.: "On the Efficacy of screening for breast cancer". International J. Epidemiol., 2004, 33, 43.

[9] IARC Working Group on Cervical Cancer Screening. Summary chapter, 133-141. In: Hakama M, Miller AB,Day NS, eds. "Screening for Cancer of the Uterine Cervix" IARC Scientific Publications No. 76, IARC, Lyon, 1986.

[10] F ranco L.E., Duarte-Franco E., Rohan T.E.: "Evidence-based policy recommendations on cancer screening and prevention". Cancer Detect. Prev., 2002, 26, 350.

[11] Ronco G., Segnan N., Giorgi-Rossi P., Zappa M., Casadei G.P., Carozzi F. et al.: "Human papillomavirus testing and liquid-based cytology: results at recruitment from the new technologies for cervical cancer randomized controlled trial". J. Natl. Cancer Inst., 2006, 98, 765.

[12] Mandel J.S., Bond J.H., Church T.R., Snover D.C., Bradley G.M., Schuman L.M., Ederer F.: "Reducing mortality from colorectal cancer by screening for fecal occult blood. Minnesota Colon Cancer Control Study". N. Engl. J. Med., 1993, 328, 1365.

[13] Toweler B.P., Irwig L., Glasziou P., Welle D., Kewenter J.: "Screening for colorectal cancer using the faecal occult blood test, hemoccult". C ochrane Database Syst. Rev., 2000, 2, CD001216.

[14] La Rosa F., RTUP working Group. La frequenza de! cancro in Umbria. 1994-2002. Regione dell'Umbria, Perugia, 2005.

[15] Mastrandrea V., Vitali R., La Rosa F., Petrinelli A.M.: "Incidenzae mortalita per tumori maligni in Umbria (1978-1982)". Regione dell'Umbria, Perugia, 1988.

[16] WHO. International statistical classification of diseases and related health problems, tenth revision (ICD-10). World Health Organisation, Geneva, 1992.

[17] Parkin D.M., Chen W., Ferlay J., Galceran J., Storm W.H., Whelan S.L.: "Comparability and quality control in cancer registration". IARC Tech Rep n. 19, Lyon, 1994.

[18] Esteve J., Benhamou E., Croasdale M., Raymond L.: "Relative survival and the estimation of net survival: elements for further discussion". Stat. Med., 1990, 9, 529.

[19] Coleman M.P., Babb P., Damiecki P., Grosclaude P., Honjo S., Jones J., Knerer G., Pitard A., Quinn M., Sloggett A., De Stavola B.: "Cancer survival trends in England and Wales 1971-1995 deprivation and NHS region". Series SMPS No. 61. The Stationery Office, London, 1999.

[20] Levi F., Lucchini F., Negri E., Franceschi S., La Vecchia C.: "Cervical cancer mortality in young women in Europe: patterns and trends". Eur. J. Cancer, 2000, 26, 2266.

[21] Minelli L., Stracci F., Prandini S., Fusco-Moffa I., La Rosa F "Gynaecological cancers in Umbria (Italy): trends of incidence, mortality and survival, 1978-1998". Eur. J. Obst et. Gynecol. Rep Biol., 2004, ll5, 59.

[22] Zambon P., La Rosa F.: "Gynecological cancers: cervix, corpus uteri, ovary". Epidemiol. Prev., 2004, 28 (2 suppl.), 68.

[23] Levi F., Lucchini F., Negri E., Zatonski W., Boyle P., La Vecchia C.:'Trends in cancer mortality in the European Union and accession countries, 1980-2000". Ann. Oneal., 2004, 15, 1425.

[24] Paci E., Pannelli F.: "Female breast cancer". Epidemiol. Prev., 2004, 28 (suppl. 2), 64.

[25] Levi F., Bosetti C., Lucchini F., Negri E., La Vecchia C.: "Momtoring the decrease in breast cancer mortality in Europe". Eur. J. Cancer Pre,,.，2005, 14, 497.

[26] Sant M., Francisci S., Capocaccia R., Verdecchia A., Allemani C., Berrino F.: "Time trend of breast cancer survival in Europe in relation to incidence and mortality". Int. J. Cancer, 2006, 119, 2417.

[27] Paci E., Ponti A., Zappa M., Patriarca S., Falini P., Delmastro G et al.: "Early diagnosis, not differential treatment, explains better survival in service screening". Eur. J. Cancer, 2005, 41, 2728.

[28] Cortesi L.. Chiuri VE.. Ruscelli S., Bellelli V.. Negri R., Rashid I et al.: "Prognosis of screen-detected breast cancer: results of a population based study". ENC Cancer, 2006, 6, 17.

[29] Rosso S., Casella C., Crocetti E.: "Sopravvivenza dei casi di tumore in Italia negli anni novanta: i dati dei Registri Tumori". Epidemiol. Prev., 2001. 25 (suppl. 3), 1.

[30] Cassetti T., Stracci F., CanosaA.. Minelli L., Scheibel M., Romagnoli C., La Rosa F.: "Epidemiology of colorectal cancer in the Umbria region of Italy: pre-screening period". Tumori, 2007, 93, 13.